716 results on '"Sokoll, Lori J."'
Search Results
2. Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex
3. VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
4. Proficiency Testing Customization in Clinical Trials: How the pSMILE Project Ensures High-Quality Proficiency Testing Coverage for International Laboratories.
5. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm
6. Prevalence of Detectable Biotin in Five US Emergency Department Patient Cohorts
7. Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification
8. The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
9. Malignancy-associated endocrine disorders
10. List of Contributors
11. Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
12. Tumor markers
13. Immunoassays
14. List of contributors
15. Validation of the Novel GLAS Algorithm for Early Detection of Liver Fibrosis and Cirrhosis Based on GP73, LG2m, Age, and Sex
16. A novel internal training program using Kern’s 6-step approach to curriculum development for medical laboratory scientists training to be international quality assurance/quality control coordinators
17. Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol
18. Validation of a novel model for the early detection of hepatocellular carcinoma
19. Data from Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer
20. Supplementary Figures S1-S2 from Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer
21. Supplementary Data from Pro–Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer
22. Supplementary Figures 1-2 from Initial Analyses of Colon Cancer–Specific Antigen (CCSA)-3 and CCSA-4 as Colorectal Cancer–Associated Serum Markers
23. Urinary Biomarkers for Prostate Cancer
24. Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA
25. A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
26. Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
27. Differentially expressed glycoproteins in pre‐ and post‐digital rectal examination urine samples for detecting aggressive prostate cancer
28. Low High-Sensitivity Troponin I and Zero Coronary Artery Calcium Score Identifies Coronary CT Angiography Candidates in Whom Further Testing Could be Avoided
29. Additional file 1 of VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
30. Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance
31. Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy
32. Prostate Health Index density improves detection of clinically significant prostate cancer
33. Specificity and Confirmation of SARS-CoV-2 Serological Test Methods in Emergency Department Populations across the United States
34. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults
35. Insight into infection‐mediated prostate damage: Contrasting patterns of C‐reactive protein and prostate‐specific antigen levels during infection
36. Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer
37. Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay
38. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests
39. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy
40. Free Thyroxine Distinguishes Subclinical Hypothyroidism From Other Aging-Related Changes in Those With Isolated Elevated Thyrotropin
41. Immunoassay-Based Tumor Marker Measurement: Assays, Applications, and Algorithms
42. A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
43. Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays
44. Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection
45. The Creation of a Biocontainment Unit at a Tertiary Care Hospital. The Johns Hopkins Medicine Experience
46. Do Ultrasensitive Prostate Specific Antigen Measurements Have a Role in Predicting Long-Term Biochemical Recurrence-Free Survival in Men after Radical Prostatectomy?
47. Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program
48. Proteogenomic characterization of pancreatic ductal adenocarcinoma
49. Human Immunodeficiency Virus Load in Breast Milk, Mastitis, and Mother-to-Child Transmission of Human Immunodeficiency Virus Type 1
50. Chapter 12 - Malignancy-associated endocrine disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.